Announced
Synopsis
Medios, a pharmaceutical company, agreed to acquire NewCo Pharma, a provider of patient-specific infusion solutions, for €125m. This enables Medios to significantly expand its business activities in the segment of patient-specific therapies throughout Germany.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.